EVALUATION OF THE IMPACT OF METABOLIC SYNDROME ON CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME

Cardiovascular diseases (CVD) still remain the main cause of death in Uzbekistan [2]. Conducted clinical studies demonstrate the high prevalence of metabolic syndrome (MS) and its adverse effect on the course and prognosis of patients with acute coronary syndrome [3-9]. However, the results of studies on long-term prognosis in patients with MS who have had acute ST elevation myocardial infarction (STEMI) are somewhat contradictory, since different criteria have been used to diagnose MS. The studies mainly used the ATP-III or IDF criteria, but for the diagnosis of MS in studies conducted in Japan, the ATP-III criteria were modified taking into account national recommendations [4,7,10]. In the Uzbek population, for the diagnosis of MS, the criteria for GFCF [1] are used, with the use of which similar studies have not been carried out. In this regard, this study was planned, in which the diagnosis of MS was carried out according to the criteria for GFCF.